Detalhe da pesquisa
1.
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.
Blood
; 141(3): 295-308, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260765
2.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
3.
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Lancet Oncol
; 25(3): 388-399, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423051
4.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Blood
; 140(17): 1845-1857, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917453
5.
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.
Blood
; 139(23): 3366-3375, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081255
6.
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.
Blood
; 139(24): 3546-3557, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286378
7.
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 331(21): 1814-1823, 2024 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722621
8.
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.
Blood
; 138(5): 387-400, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351368
9.
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia.
Ann Hematol
; 102(11): 3049-3059, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702821
10.
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.
N Engl J Med
; 380(17): 1628-1637, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018069
11.
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.
Haematologica
; 107(5): 1034-1044, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261293
12.
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes.
Ann Hematol
; 101(8): 1689-1701, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488900
13.
MDM2 and BCL-2: to p53 or not to p53?
Blood
; 141(11): 1237-1238, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929437
14.
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.
Blood
; 141(12): 1489-1493, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493344
15.
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study.
Ann Hematol
; 99(9): 2119-2124, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676733
16.
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 114(23): E4641-E4647, 2017 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533390
17.
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019.
J Natl Compr Canc Netw
; 17(5): 414-423, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085755
18.
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(6): 721-749, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200351
19.
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 19(7): 889-903, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29859851
20.
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.
Blood
; 128(13): 1671-8, 2016 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27421961